ABCG2 and colorectal carcinoma: [20] A representative analysis is presented in Figure 1F. These data may indicate that ABCC4 is a prevalent drug transporter in primary tumors in which ABCG2 is downregulated, and confirm the hypothesis that the changes in the ABC transporter expression might be related to the various stages of CRC progression.